SOURCE: Edwards Lifesciences

Edwards Lifesciences

November 14, 2013 16:52 ET

Edwards Comments on German Appellate Court Ruling

IRVINE, CA--(Marketwired - Nov 14, 2013) - Edwards Lifesciences Corporation (NYSE: EW), the global leader in the science of heart valves and hemodynamic monitoring, today said that an appeals court in Germany has suspended the enforcement of an injunction against sales of Medtronic's transcatheter heart valves in Germany, pending the posting of a EUR 5 million bond by Medtronic. This action comes after the European Patent Office (EPO) issued a non-binding preliminary opinion in October indicating concerns about the validity of the Edwards Spenser patent. 

About Edwards Lifesciences
Edwards Lifesciences is the global leader in the science of heart valves and hemodynamic monitoring. Driven by a passion to help patients, the company partners with clinicians to develop innovative technologies in the areas of structural heart disease and critical care monitoring, enabling them to save and enhance lives. Additional company information can be found at

Edwards, Edwards Lifesciences, and the stylized E logo are trademarks of Edwards Lifesciences Corporation.

Contact Information

  • Media Contact:
    Sarah Huoh

    Investor Contact:
    David K. Erickson